Drugmaker, Watson Pharmaceuticals Inc | featured news

Welcome to Wopular's coverage of Drugmaker, Watson Pharmaceuticals Inc. Wopular aggregates news headlines from the top newspapers and news sources. To the right are articles about Drugmaker, Watson Pharmaceuticals Inc that have been featured on main sections of the site.

Below are topics about Drugmaker, Watson Pharmaceuticals Inc. (Click on "all" to view all articles related to the topic, including articles NOT about Drugmaker, Watson Pharmaceuticals Inc.

Click here to search news sites, aggregators, and blogs as well as videos, photos, and websites about Drugmaker, Watson Pharmaceuticals Inc.

Bookmark or Share

Main Topics

Drugmaker Topics

Exclusive: Watson close to $7 billion Actavis drug deal: sources

Watson Acquires Actavis

Watson Pharmaceuticals Inc is close to buying Swiss-based Actavis for around $7 billion, marking the latest deal between generics companies racing to achieve economies of scale, three sources familiar with the matter said.

 

Subscribe to this RSS topic: Syndicate content